LUNG

2.46

5.58% 0.13

Vorhandelsmarkt: 2.46

Pulmonx Corp (LUNG)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.33

Offen:

$2.3

24-Stunden-Volumen:

1.64M

Relative Volume:

0.68

Marktkapitalisierung:

$101.47M

Einnahmen:

$68.68M

Nettoeinkommen (Verlust:

$-60.84M

KGV:

-1.5375

EPS:

-1.6

Netto-Cashflow:

$-38.42M

1W Leistung:

+30.16%

1M Leistung:

+26.80%

6M Leistung:

-27.65%

1J Leistung:

-62.61%

1-Tages-Spanne:

$2.25

$2.50

1-Wochen-Bereich:

$1.85

$2.50

52-Wochen-Spanne:

$1.31

$9.37

Pulmonx Corp Stock (LUNG) Company Profile

Firmenname

Pulmonx Corp

Sektor

Healthcare (1124)

Branche

Medical Devices (143)

Telefon

650-364-0400

Adresse

700 CHESAPEAKE DRIVE, REDWOOD CITY

Mitarbeiter

291

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

LUNG's Discussions on Twitter

Vergleichen Sie LUNG mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LUNG Pulmonx Corp	2.46	96.11M	68.68M	-60.84M	-38.42M	-1.60
ABT Abbott Laboratories	122.55	210.84B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	92.70	137.17B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	353.80	133.55B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	100.77	127.71B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.92	48.33B	5.88B	1.34B	799.60M	2.3489

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-31	Herabstufung	Piper Sandler	Overweight → Neutral
2025-03-10	Eingeleitet	D. Boral Capital	Buy
2024-12-11	Herabstufung	Citigroup	Buy → Neutral
2024-06-04	Eingeleitet	Lake Street	Buy
2024-02-23	Herabstufung	Wells Fargo	Overweight → Equal Weight
2023-09-05	Eingeleitet	Craig Hallum	Buy
2023-02-27	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-01-03	Herabstufung	BofA Securities	Neutral → Underperform
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2021-12-08	Hochstufung	Piper Sandler	Neutral → Overweight
2021-04-01	Eingeleitet	Citigroup	Buy
2021-03-25	Eingeleitet	Piper Sandler	Neutral
2021-03-10	Hochstufung	BofA Securities	Neutral → Buy
2021-01-04	Herabstufung	BofA Securities	Buy → Neutral
2020-10-26	Eingeleitet	BofA Securities	Buy
2020-10-26	Eingeleitet	Canaccord Genuity	Buy
2020-10-26	Eingeleitet	Morgan Stanley	Equal-Weight
2020-10-26	Eingeleitet	Stifel	Buy
2020-10-26	Eingeleitet	Wells Fargo	Equal Weight

Alle ansehen

Pulmonx Corp Aktie (LUNG) Neueste Nachrichten

Dec 09, 2025

Insider Selling: Daniel Florin Sells Shares of Pulmonx Corp (LUN - GuruFocus

Dec 09, 2025

Dec 08, 2025

Check out these key findings about Pulmonx Corp (LUNG) - Setenews

Dec 08, 2025

Dec 07, 2025

Pulmonx (LUNG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 07, 2025

Dec 05, 2025

Improved Revenues Required Before Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Jump Looks Justified - simplywall.st

Dec 05, 2025

Dec 04, 2025

Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock - MarketBeat

Dec 04, 2025

Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares - MarketBeat

Dec 04, 2025

Dec 03, 2025

Pulmonx CEO French sells $13.8k in LUNG stock - Investing.com India

Dec 03, 2025

Pulmonx CEO French sells $13.8k in LUNG stock By Investing.com - Investing.com Canada

Dec 03, 2025

Pulmonx Corp General Counsel Sells Shares to Cover Tax Obligations - TradingView

Dec 03, 2025

LUNG FinancialsIncome Statement - Quiver Quantitative

Dec 03, 2025

Pulmonx Corporation Grants 1,625,000 Equity Awards as Part of 2025 Inducement Plan - Quiver Quantitative

Dec 03, 2025

Pulmonx (Nasdaq: LUNG) issues 1,625,000-share inducement grants, incl. 1.6M RSUs/PSUs - Stock Titan

Dec 03, 2025

Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of “Hold” by Brokerages - Defense World

Dec 03, 2025

Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Dec 03, 2025

Dec 02, 2025

Check Out Pulmonx Corp (LUNG)’s Trade Data Rather Than the Analysts’ Views - Setenews

Dec 02, 2025

Nov 27, 2025

Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World

Nov 27, 2025

How Pulmonx Corporation stock performs in interest rate cyclesQuarterly Performance Summary & AI Powered Market Entry Strategies - BỘ NỘI VỤ

Nov 27, 2025

Nov 24, 2025

[S-3/A] Pulmonx Corp Amended Shelf Registration Statement | LUNG SEC FilingForm S-3/A - Stock Titan

Nov 24, 2025

[S-8] Pulmonx Corp Employee Benefit Plan Registration | LUNG SEC FilingForm S-8 - Stock Titan

Nov 24, 2025

Holdings of Pulmonx Corp (LUNG) are aligned with the stars - Setenews

Nov 24, 2025

Nov 21, 2025

Pulmonx Corporation (LUNG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025

Nov 19, 2025

Technical signs of recovery in Pulmonx CorporationQuarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com

Nov 19, 2025

Is Pulmonx Corporation stock attractive for hedge fundsWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com

Nov 19, 2025

Will Pulmonx Corporation stock sustain high P E ratios2025 Major Catalysts & Growth Focused Entry Reports - newser.com

Nov 19, 2025

Nov 18, 2025

Pulmonx Corporation (LUNG) stock price, news, quote and history - Yahoo Finance UK

Nov 18, 2025

Is Pulmonx Corporation stock trading at a premium valuationAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com

Nov 18, 2025

Nov 17, 2025

A significant driver of top-line growth: Pulmonx Corp (LUNG) - Setenews

Nov 17, 2025

Nov 16, 2025

Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen - Defense World

Nov 16, 2025

Nov 15, 2025

Is Pulmonx Corporation stock entering bullish territoryProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 15, 2025

Can Pulmonx Corporation stock outperform in 2025 bull marketWeekly Trade Recap & Safe Capital Preservation Plans - newser.com

Nov 15, 2025

Tick level data insight on Pulmonx Corporation volatility2025 Valuation Update & Precise Buy Zone Identification - newser.com

Nov 15, 2025

Historical volatility pattern of Pulmonx Corporation visualizedTrade Analysis Report & Long-Term Safe Return Strategies - newser.com

Nov 15, 2025

Nov 14, 2025

Pulmonx Corporation (NASDAQ:LUNG) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

Pulmonx (NASDAQ:LUNG) Receives "Buy" Rating from D. Boral Capital - MarketBeat

Nov 14, 2025

Nov 13, 2025

Pulmonx Rides Global Growth On Strong Zephyr Valve Demand - Finimize

Nov 13, 2025

Pulmonx stock rating reiterated at Buy by Stifel after 3Q results - Investing.com Nigeria

Nov 13, 2025

LUNG Stock Rating: D. Boral Capital Maintains Buy Rating with $1 - GuruFocus

Nov 13, 2025

How Recent Shifts Are Rewriting the Story for Pulmonx - Yahoo Finance

Nov 13, 2025

Pulmonx (NASDAQ:LUNG) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Nov 13, 2025